Abstract
Objective To use life tables to model the differences in life expectancy for people with and without disabilities in low- and middle-income countries (LMICs).
Methods We used data from a recent conducted a meta-analysis of analysis which gathered data from 70 studies to determine Hazard Ratios (HRs) for all-cause mortality by disability status for children 0-15, adults 15-59, and adults 60+, using the World Health Organisation’s definition of disability. To assess the disparities in life expectancy among people with disabilities across 136 low and middle-income countries (LMICs), we constructed life tables using these HRs.gap compared to the population average. These calculations were based on the 2020 United Nations population projections. The life expectancy gap was meta-analysed across countries to calculate the mean difference.
Findings People with disabilities in LMIC had a mean life expectancy of 49.3 years (95%C.I. 47.4 – 51.2), compared to 68.5 years (95% C.I. 67.4 – 69.5) for the general population, giving a median gap of 19.2 years (95% C.I. 18.3 – 20.1). The disparity in life expectancy varied across countries, ranging from 9.6 years (95% C.I. 4.7 – 17.4) in Bosnia and Herzegovina to 30.6 years (95% C.I. 16.9 – 40.6) in Nigeria.
Conclusion Life expectancy inequities represent an urgent threat to upholding the rights of persons with disabilities and achieving global goals. It is crucial to address the disparities in social determinants of health, and prioritise the inclusion of people with disabilities within health equity efforts to close this gap.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SR receives funding from the Rhodes Trust. TS and HK are supported by an NIHR Global Research Professorship (301621).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: SR receives funding from the Rhodes Trust. TS and HK are supported by an NIHR Global Research Professorship (301621).
Competing interests: The authors declare no competing interests.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
